Target intelligence / Profile preview

DNA repair mechanism (None)

Target
None
Molecular classification
Other (cellular process), Enzyme, Protein complex
01

Overview

The term "DNA repair mechanism" refers collectively to several highly conserved cellular processes that detect and correct damage or errors occurring within the genetic material. These mechanisms include direct reversal repairs like photoreactivation; excision-based repairs such as base excision and nucleotide excision; mismatch correction systems; double-strand break repairs via homologous recombination or non-homologous end joining; and error-prone emergency responses like SOS induction. Each pathway involves distinct sets of proteins—enzymes like glycosylases, ligases, nucleases—and multi-protein complexes that work together to maintain genome stability by preventing accumulation of mutations that could otherwise lead to cell death or transformation into cancer cells[1][2][3]. While individual proteins within these systems are valid therapeutic targets—especially in oncology—the umbrella term "DNA repair mechanism" does not denote any one druggable entity but rather describes essential biological functions critical for life across all domains[4].

Other names
DNA damage repairDNA maintenance mechanismsGenome stability pathways
02

Mechanism of action

Not applicable at the level of "DNA repair mechanism."

03

Biological functions

Maintenance of genome integrityCorrection of DNA replication errorsResponse to genotoxic stressPrevention of mutations
04

Disease associations

Cancer (defects in DNA repair are major contributors to carcinogenesis)Neurodegenerative disease (impaired DNA repair linked to some disorders)Aging-related diseasesOther genetic instability syndromes
05

Safety considerations

Targeting global DNA repair can lead to genomic instability and toxicitySpecific inhibition may sensitize normal cells alongside cancer cellsResistance development due to compensatory upregulation of alternative pathways
06

Biomarkers

Deficiency markers for pathway components such as BRCA1/BRCA2 mutations indicate homologous recombination deficiencyMicrosatellite instability indicates mismatch repair deficiency

Beyond the preview

Go deeper on DNA repair mechanism (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA repair mechanism (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call